LEGN: Zhang Ingrid discloses securities transactions

By AlphaYouPublished Sep 16, 2026Form 4

Stocks in this disclosure

Reported activity

Zhang Ingrid

Reporting filer

Zhang Ingrid reported Grant or award in Legend Biotech Corp: 1131860 units of Ordinary Shares, dated 2026-09-15. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 16, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Ordinary Shares	Zhang Ingrid	2026-09-15	A	Grant or award	1131860	0	1,131,860	1 day	Filed terms security Title: Ordinary Shares id: F1 transaction Date: 2026-09-15 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 1131860 id: F2 transaction Price Per Share: 0 transaction Acquired Disposed Code: A shares Owned Following Transaction: 1131860 direct Or Indirect Ownership: D nature Of Ownership:

Ordinary Shares

Owner: Zhang Ingrid
Date: 2026-09-15
Code: A
Action: Grant or award
Quantity: 1131860
Price: 0
Following holdings: 1,131,860
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Ordinary Shares
id: F1
transaction Date: 2026-09-15
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 1131860
id: F2
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 1131860
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Zhang Ingrid: Chief Executive Officer.
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
F2: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of September 15, 2027, September 15, 2028, and September 15, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Ordinary Shares

Zhang Ingrid

2026-09-15

Grant or award

1131860

1,131,860

1 day

Filed terms

security Title: Ordinary Shares
id: F1
transaction Date: 2026-09-15
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 1131860
id: F2
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 1131860
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Zhang Ingrid: Chief Executive Officer.

F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

F2: Represents restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of September 15, 2027, September 15, 2028, and September 15, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date.